Daniel J. Friedman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel J. Friedman has a total of 433 co-authors. Here are the top co-authors by number of shared publications:
James V. Freeman
13 shared publicationsJeptha P. Curtis
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut
13 shared publications- Jonathan P. Piccini
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC (J.P.P.).
12 shared publications Sana M. Al-Khatib
11 shared publications- James V. Freeman
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut
10 shared publications - Sana M. Al-Khatib
Division of Cardiology, Duke University Medical Center, Durham, NC (S.M.A.-K.).
8 shared publications
Latest Publications
- 11 September 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
Frequency and Extent of Leadless Pacemaker Encapsulation
- 11 September 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
Frequency and Extent of Leadless Pacemaker Encapsulation
- Open Access
- 2 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (5)
Risk of atrial fibrillation according to electrocardiographic risk factors: a nationwide cohort study of 1.5 million patients
Aims: Atrial fibrillation (AF) is associated with an increased risk of stroke, yet no evidence exists on the collective effect of electrocardiogram (ECG) risk factors in early detection of AF. We aimed to evaluate the risk of new-onset AF and stroke according to specific ECG risk factors to identify patients at high risk of developing AF. Methods and results: We included patients who had an ECG performed and grouped them according to how many of the following ECG risk factors they presented with: Elevated heart rate at rest, prolonged PR-interval, biphasic P-waves, abnormal P-terminal force in V1, and prolonged P-wave duration. Among 1 434 491 included patients, 632 628 had none of the five ECG risk factors and 802 163 had at least one ECG risk factor on their ECG. The 5-year cumulative incidence of AF and stroke was lowest among patients with no ECG changes and exceeded 8% and 7%, respectively among patients with all five ECG risk factors [AF: 8.3%, 95% confidence interval (CI): 5.7–11.0%, stroke: 7.3%, 95% CI: 4.7–9.9%]. Patients with all five ECG risk factors had a two-fold increased risk of AF [hazard ratio (HR): 2.57, 95% CI: 1.85–3.57] and of stroke (HR: 2.11, 95% CI: 1.47–3.01) compared to patients with none. Conclusion: The selected ECG risk factors were commonly observed. The 5-year incidence of AF and stroke was low among patients with no ECG risk factors, yet increased in a dose–response-like manner according to the number of ECG risk factors. Scoring patients according to simple ECG risk factors effectively identified patients at high risk of AF and stroke.
- 2 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (5)
Open AccessRisk of atrial fibrillation according to electrocardiographic risk factors: a nationwide cohort study of 1.5 million patients
Aims: Atrial fibrillation (AF) is associated with an increased risk of stroke, yet no evidence exists on the collective effect of electrocardiogram (ECG) risk factors in early detection of AF. We aimed to evaluate the risk of new-onset AF and stroke according to specific ECG risk factors to identify patients at high risk of developing AF. Methods and results: We included patients who had an ECG performed and grouped them according to how many of the following ECG risk factors they presented with: Elevated heart rate at rest, prolonged PR-interval, biphasic P-waves, abnormal P-terminal force in V1, and prolonged P-wave duration. Among 1 434 491 included patients, 632 628 had none of the five ECG risk factors and 802 163 had at least one ECG risk factor on their ECG. The 5-year cumulative incidence of AF and stroke was lowest among patients with no ECG changes and exceeded 8% and 7%, respectively among patients with all five ECG risk factors [AF: 8.3%, 95% confidence interval (CI): 5.7–11.0%, stroke: 7.3%, 95% CI: 4.7–9.9%]. Patients with all five ECG risk factors had a two-fold increased risk of AF [hazard ratio (HR): 2.57, 95% CI: 1.85–3.57] and of stroke (HR: 2.11, 95% CI: 1.47–3.01) compared to patients with none. Conclusion: The selected ECG risk factors were commonly observed. The 5-year incidence of AF and stroke was low among patients with no ECG risk factors, yet increased in a dose–response-like manner according to the number of ECG risk factors. Scoring patients according to simple ECG risk factors effectively identified patients at high risk of AF and stroke.
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (9)
Pulsed Field Ablation Therapy Parameters: Enhancing Lesion Depth While Reducing Musculoskeletal Stimulation and Thermal Response in an Irrigated Tip Catheter: A Comprehensive Study Using In Silico, In Vitro, and In Vivo Models
BACKGROUND: Pulsed field ablation therapies need to be optimized to maximize lesion depth while mitigating heat and musculoskeletal stimulation. We describe the adjustment of biphasic pulsed field ablation parameters for an irrigated tip catheter. METHODS: Experimental models all used an 8F, flexible-tip, irrigated ablation catheter. Computer simulation models were designed to assess the effects of bipolar versus monopolar applications. A vegetal (potato) model was used to assess the effects of voltage, pulse width, and number of pulses per burst on lesion depth. In-vitro testing on bovine cardiac muscle was performed with temperature sensors at the surface and 3 and 7 mm beneath the surface to measure temperature rises. Finally, an in vivo canine model was used to assess for musculoskeletal stimulation caused by the pulsed field ablation therapies established with the vegetal/in vitro testing. RESULTS: Monopolar delivery consistently delivered more tissue depth than bipolar configurations. Adjustments from n to n+1.0 µs and increasing pulses per burst from 50 to 250 increased lesion depth but also increased musculoskeletal stimulation. The optimized burst count was 5 R-wave-gated bursts over 4 to 9 seconds. The optimized therapy had a minimal observed depth of >5 mm and minimized musculoskeletal stimulation. Final selected therapies did create temperature rises, which were completely offset by irrigation rates of 7 to 13 mL/min. CONCLUSIONS: Pulse width and number of pulses per burst are important contributors to lesion depth, musculoskeletal stimulation, and incident heating. Even small adjustments in these parameters can alter lesion depth, muscle stimulation, and thermal effects, which will differentiate optimal from suboptimal pulsed field ablation.
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (9)
Open AccessPulsed Field Ablation Therapy Parameters: Enhancing Lesion Depth While Reducing Musculoskeletal Stimulation and Thermal Response in an Irrigated Tip Catheter: A Comprehensive Study Using In Silico, In Vitro, and In Vivo Models
BACKGROUND: Pulsed field ablation therapies need to be optimized to maximize lesion depth while mitigating heat and musculoskeletal stimulation. We describe the adjustment of biphasic pulsed field ablation parameters for an irrigated tip catheter. METHODS: Experimental models all used an 8F, flexible-tip, irrigated ablation catheter. Computer simulation models were designed to assess the effects of bipolar versus monopolar applications. A vegetal (potato) model was used to assess the effects of voltage, pulse width, and number of pulses per burst on lesion depth. In-vitro testing on bovine cardiac muscle was performed with temperature sensors at the surface and 3 and 7 mm beneath the surface to measure temperature rises. Finally, an in vivo canine model was used to assess for musculoskeletal stimulation caused by the pulsed field ablation therapies established with the vegetal/in vitro testing. RESULTS: Monopolar delivery consistently delivered more tissue depth than bipolar configurations. Adjustments from n to n+1.0 µs and increasing pulses per burst from 50 to 250 increased lesion depth but also increased musculoskeletal stimulation. The optimized burst count was 5 R-wave-gated bursts over 4 to 9 seconds. The optimized therapy had a minimal observed depth of >5 mm and minimized musculoskeletal stimulation. Final selected therapies did create temperature rises, which were completely offset by irrigation rates of 7 to 13 mL/min. CONCLUSIONS: Pulse width and number of pulses per burst are important contributors to lesion depth, musculoskeletal stimulation, and incident heating. Even small adjustments in these parameters can alter lesion depth, muscle stimulation, and thermal effects, which will differentiate optimal from suboptimal pulsed field ablation.
- Top Cited Papers
- 28 August 2026
- Published by Elsevier in Heart Rhythm
Incidence of atrial fibrillation in pacemaker patients with left bundle branch area pacing vs right ventricular pacing leads
- 28 August 2026
- Published by Elsevier in Heart Rhythm
Top Cited PapersIncidence of atrial fibrillation in pacemaker patients with left bundle branch area pacing vs right ventricular pacing leads
- 20 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (9) , 2047-2054
Mechanisms of Recurrent Arrhythmia in Patients With Prior Surgical Ablation of Atrial Fibrillation Who Undergo Catheter Ablation
Background: Atrial tachyarrhythmias frequently recur after surgical ablation and often require catheter ablation (CA). Methods: We conducted a retrospective cohort study of patients who underwent CA for symptomatic atrial fibrillation or flutter (AF hereafter) following surgical ablation. Clinical data, including patient and surgical characteristics and results of electrophysiology testing and mapping, were recorded. Recurrence was defined as 30 s of AF, atrial flutter, or atrial tachycardia following a 3‐month blanking period. Results: Thirty‐seven patients were included in the study (mean age 67.0 ± 9.8 years, 43% female) who underwent isolated surgical ablation ( n = 5), concomitant mitral valve surgery ( n = 21), aortic valve ( n = 5), tricuspid valve surgery ( n = 6), and/or coronary artery bypass grafting ( n = 6). The mean time from surgical ablation to CA was 5.9 ± 5.1 years. Among the 37 patients, 19 (51%) experienced one or more pulmonary vein reconnections (mean 3.0 ± 1.3 veins per patient), and 15 (41%) developed mitral annular flutter. Following ablation, 12 (32%) patients developed recurrent arrhythmia by 1‐year post‐ablation. Age, sex, body mass index, time from surgical ablation to CA left ventricular ejection fraction < 50%, prior CA, left atrial diameter, and mitral annular flutter were not associated with recurrence. The number of pulmonary vein reconnections at the time of repeat CA was predictive of arrhythmia recurrence in subsequent follow‐up (OR 2.148 [95% CI: 1.059−4.357]; p = 0.034). Conclusions: Pulmonary vein reconnection and mitral annular flutter are common recurrence mechanisms in patients with symptomatic arrhythmia recurrence following surgical ablation. The number of pulmonary vein reconnections predicts recurrent arrhythmia.
- 20 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (9) , 2047-2054
Mechanisms of Recurrent Arrhythmia in Patients With Prior Surgical Ablation of Atrial Fibrillation Who Undergo Catheter Ablation
Background: Atrial tachyarrhythmias frequently recur after surgical ablation and often require catheter ablation (CA). Methods: We conducted a retrospective cohort study of patients who underwent CA for symptomatic atrial fibrillation or flutter (AF hereafter) following surgical ablation. Clinical data, including patient and surgical characteristics and results of electrophysiology testing and mapping, were recorded. Recurrence was defined as 30 s of AF, atrial flutter, or atrial tachycardia following a 3‐month blanking period. Results: Thirty‐seven patients were included in the study (mean age 67.0 ± 9.8 years, 43% female) who underwent isolated surgical ablation ( n = 5), concomitant mitral valve surgery ( n = 21), aortic valve ( n = 5), tricuspid valve surgery ( n = 6), and/or coronary artery bypass grafting ( n = 6). The mean time from surgical ablation to CA was 5.9 ± 5.1 years. Among the 37 patients, 19 (51%) experienced one or more pulmonary vein reconnections (mean 3.0 ± 1.3 veins per patient), and 15 (41%) developed mitral annular flutter. Following ablation, 12 (32%) patients developed recurrent arrhythmia by 1‐year post‐ablation. Age, sex, body mass index, time from surgical ablation to CA left ventricular ejection fraction < 50%, prior CA, left atrial diameter, and mitral annular flutter were not associated with recurrence. The number of pulmonary vein reconnections at the time of repeat CA was predictive of arrhythmia recurrence in subsequent follow‐up (OR 2.148 [95% CI: 1.059−4.357]; p = 0.034). Conclusions: Pulmonary vein reconnection and mitral annular flutter are common recurrence mechanisms in patients with symptomatic arrhythmia recurrence following surgical ablation. The number of pulmonary vein reconnections predicts recurrent arrhythmia.
- Open Access
- 2 July 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (10) , 1979-1989
Refining cardiac resynchronization therapy selection in borderline QRS duration patients
- 2 July 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (10) , 1979-1989
Open AccessRefining cardiac resynchronization therapy selection in borderline QRS duration patients
- 24 June 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (11) , e2681-e2691
Atrial fibrillation ablation energy source transition and adjunctive lesion set utilization after commercial release of pulse field ablation
- 24 June 2026
- Published by Elsevier in Heart Rhythm
- Vol. 23 (11) , e2681-e2691
Atrial fibrillation ablation energy source transition and adjunctive lesion set utilization after commercial release of pulse field ablation
- 29 May 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (10) , 2503-2515
Outcomes of Patients With Reduced Left Ventricular Function Undergoing Left Atrial Appendage Occlusion
- 29 May 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (10) , 2503-2515
Outcomes of Patients With Reduced Left Ventricular Function Undergoing Left Atrial Appendage Occlusion
- Open Access
- 20 January 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (2) , 102540
Using Machine Learning to Predict Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion
- 20 January 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (2) , 102540
Open AccessUsing Machine Learning to Predict Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion